title: Effects of viscosity and osmotic stress on the reaction of human butyrylcholinesterase with cresyl saligenin phosphate, a toxicant related to aerotoxic syndrome: kinetic and molecular dynamics studies.
abstract: CSP (cresyl saligenin phosphate) is an irreversible inhibitor of human BChE (butyrylcholinesterase) that has been involved in the aerotoxic syndrome. Inhibition under pseudo-first-order conditions is biphasic, reflecting a slow equilibrium between two enzyme states E and E'. The elementary constants for CSP inhibition of wild-type BChE and D70G mutant were determined by studying the dependence of inhibition kinetics on viscosity and osmotic pressure. Glycerol and sucrose were used as viscosogens. Phosphorylation by CSP is sensitive to viscosity and is thus strongly diffusion-controlled (kon≈10⁸ M⁻¹·min⁻¹). Bimolecular rate constants (ki) are about equal to kon values, making CSP one of the fastest inhibitors of BChE. Sucrose caused osmotic stress because it is excluded from the active-site gorge. This depleted the active-site gorge of water. Osmotic activation volumes, determined from the dependence of ki on osmotic pressure, showed that water in the gorge of the D70G mutant is more easily depleted than that in wild-type BChE. This demonstrates the importance of the peripheral site residue Asp⁷⁰ in controlling the active-site gorge hydration. MD simulations provided new evidence for differences in the motion of water within the gorge of wild-type and D70G enzymes. The effect of viscosogens/osmolytes provided information on the slow equilibrium E⇌E', indicating that alteration in hydration of a key catalytic residue shifts the equilibrium towards E'. MD simulations showed that glycerol molecules that substitute for water molecules in the enzyme active-site gorge induce a conformational change in the catalytic triad residue His⁴³⁸, leading to the less reactive form E'.
authors.affiliation: Eppley Institute, University of Nebraska Medical Center, Omaha, NE 68198-5950, USA. pmasson@unmc.edu
authors.forename: Patrick
authors.initials: P
authors.lastname: Masson
authors.forename: Sofya
authors.initials: S
authors.lastname: Lushchekina
authors.forename: Lawrence M
authors.initials: LM
authors.lastname: Schopfer
authors.forename: Oksana
authors.initials: O
authors.lastname: Lockridge
mesh_terms: D002091:Butyrylcholinesterase / Q000737:chemistry* / Q000235:genetics; D020134:Catalytic Domain; D002800:Cholinesterase Inhibitors / Q000737:chemistry*; D005990:Glycerol / Q000737:chemistry; D006801:Humans; D006860:Hydrogen Bonding; D007700:Kinetics; D056004:Molecular Dynamics Simulation; D020125:Mutation, Missense; D009943:Organophosphorus Compounds / Q000737:chemistry*; D009997:Osmotic Pressure; D013395:Sucrose / Q000737:chemistry; D014783:Viscosity; D014867:Water / Q000737:chemistry
chemical_list: D002800:Cholinesterase Inhibitors; D009943:Organophosphorus Compounds; D014867:Water; C000516:2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide; D013395:Sucrose; D002091:Butyrylcholinesterase; D005990:Glycerol